Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitors in NSCLC: Insights From Pharmacovigilance Data, a Retrospective Case-control Study, and Single-cell RNA Sequencing Dataset

Clinical Therapeutics · Published 2026-07-01 · DOI 10.1016/j.clinthera.2026.06.020

Authors (7)

Xiaoyu Li, Qin Xiang, Yijia Gong, Yanyan Long, Yu He, Zhongjun Wu, Tingxiu Xiang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Li, X., Xiang, Q., Gong, Y., et al. (2026). Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitors in NSCLC: Insights From Pharmacovigilance Data, a Retrospective Case-control Study, and Single-cell RNA Sequencing Dataset. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2026.06.020

Related articles